Trial Profile
Comparison of Early Intervention of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV Patients With Initial Loading Dose
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Jan 2019
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 19 Aug 2016 New trial record